Activity value 72england Buyer&Supplier,Last transaction date:
2026-05-01Address: unit 2, iconix park,london road,pampisford,cambridge
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for aqdot ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3 transactions, with a transaction quantity of 0 and a transaction weight of 0.
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Product description
CONDENSATION OR REARRANGEMENT POLYMERIZATION PRODUCTS, WHETHER OR NOT CHEMICALLY MODIFIED, N.E.S., IN PRIMARY FORMS (EXCL. POLY OXY-1,4-PHENYLENESULPHONYL-1,4-PHENYLENEOXY-1,4-PHENYLENEISOPROPYLIDENE-1,4-PHENYLENE IN BLOCKS OF IRREGULAR SHAPE, LUMPS, POWDERS, GRANULES, FLAKES AND SIMILAR BULK FORMS AND POLY THIO-1,4-PHENYLENE)
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
Trade date
2024/12/01
B/L No.
——
Suppliers
aqdot ltd.
Buyers
——
POLs
——
PODs
——
Supply area
England
Purchas area
——
Weight
——
Amount
——
Hs code
39011010
Product tags
primary form,ravit,cific,linear,polyethylene with
Product description
LINEAR POLYETHYLENE WITH A SPECIFIC GRAVITY OF < 0,94, IN PRIMARY FORMS
Expand
Product description
HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOM[S] ONLY (EXCL. THOSE CONTAINING AN UNFUSED PYRAZOLE, IMIDAZOLE, PYRIDINE OR TRIAZINE RING, WHETHER OR NOT HYDROGENATED, A QUINOLINE OR ISOQUINOLINE RING-SYSTEM, NOT FURTHER FUSED, WHETHER OR NOT HYDROGENATED, A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE, LACTAMS, ALPRAZOLAM INN , CAMAZEPAM INN , CHLORDIAZEPOXIDE INN , CLONAZEPAM INN , CLORAZEPATE, DELORAZEPAM INN , DIAZEPAM INN , ESTAZOLAM INN , ETHYL
Expand
aqdot ltd. is england Buyer&Supplier,
and primarily engages in the import and export business of products such as clor,tazo,nitrogen.
According to the 52wmb.com global trade database, as of 2026-05-01, the company has completed 84 international trades,
with its main trading regions covering pakistan etc.
The core products include HS29339980,HS39011010,HS38099100 etc,
and its main trading partners are noble foam pvt ltd.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on aqdot ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.